QUICK LINKS
MAIN MENU
CONNECT WITH US

Button

Clinical Trial Details

Title
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV -C) as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients with Generalized Myasthenia Gravis
Study Description

This study is designed to test how well an intravenous human immunoglobulin concentrate, IGIV-C (compared with placebo) improves muscle weakness associated with Myasthenia Gravis (MG) symptoms.

Subjects will be randomized to study drug or placebo.

Investigators

Principal Investigator
Michael T. Pulley, M.D., Ph.D.
Neurology

Sub Investigator
Alan R. Berger, M.D.
Neurology

Resources

News & Announcements

Upcoming Events

There are currently no events to display. Check back soon!